AMIA urges the U.S. Department of Health and Human Services to advance a risk-based, evidence-driven framework to support responsible AI adoption in clinical care. Key barriers include limited access to representative data, insufficient infrastructure, unclear return on investment, workforce readiness gaps, and weak governance structures. We recommend transparent oversight aligned […]
It is AMIA’s position that prior authorization (PA) must be eliminated to improve patient access to necessary medical care, maintain the healthcare workforce, and reduce the required onerous documentation associated with PA. PA, the onerous process used by health insurance companies, including Medicare Advantage (MA) plans, requires clinicians to obtain […]
It is AMIA’s position that prior authorization (PA) must be eliminated to improve patient access to necessary medical care, maintain the healthcare workforce, and reduce the required onerous documentation associated with PA. PA, the onerous process used by health insurance companies, including Medicare Advantage (MA) plans, requires clinicians to obtain […]
A broad coalition of patient, scientific, and medical organizations urges Congress to swiftly pass a full-year FY2026 appropriations bill funding NIH at $48.7 billion. The letter warns that continuing resolutions and shutdowns delay grants, threaten jobs, and undermine lifesaving research, while supporting Senate provisions on multiyear grants and facilities and […]